DS Biopharma   Report issue

For profit Phase 1 Phase 2
Founded: Dublin Ireland (2010)

Organization Overview

First Clinical Trial
2015
NCT02211417
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dignity Sciences Ltd. | DS Biopharma

Active Ingredients

Drugs in Phase 2 Trials (2)

daleuton (6 trials)

hydrocortisone (solu-cortef) (1 trial)

Drugs in Phase 1 Trials (1)

Epeleuton (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 3